Free Trial
NASDAQ:COYA

Coya Therapeutics (COYA) Stock Price, News & Analysis

Coya Therapeutics logo
$6.71 +0.15 (+2.29%)
Closing price 04:00 PM Eastern
Extended Trading
$6.70 0.00 (-0.07%)
As of 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Coya Therapeutics Stock (NASDAQ:COYA)

Key Stats

Today's Range
$6.52
$6.75
50-Day Range
$5.51
$6.86
52-Week Range
$4.65
$10.24
Volume
53,091 shs
Average Volume
76,069 shs
Market Capitalization
$112.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Buy

Company Overview

Coya Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

COYA MarketRank™: 

Coya Therapeutics scored higher than 37% of companies evaluated by MarketBeat, and ranked 744th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Coya Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Coya Therapeutics has only been the subject of 4 research reports in the past 90 days.

  • Read more about Coya Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Coya Therapeutics are expected to decrease in the coming year, from ($1.15) to ($1.47) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Coya Therapeutics is -5.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Coya Therapeutics is -5.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Coya Therapeutics has a P/B Ratio of 3.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Coya Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    1.63% of the float of Coya Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Coya Therapeutics has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Coya Therapeutics has recently increased by 1.36%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Coya Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Coya Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.63% of the float of Coya Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Coya Therapeutics has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Coya Therapeutics has recently increased by 1.36%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Coya Therapeutics has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Coya Therapeutics this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    3 people have added Coya Therapeutics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Coya Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.00% of the stock of Coya Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 39.75% of the stock of Coya Therapeutics is held by institutions.

  • Read more about Coya Therapeutics' insider trading history.
Receive COYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coya Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

COYA Stock News Headlines

HC Wainwright Reaffirms "Buy" Rating for Coya Therapeutics (NASDAQ:COYA)
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Equities Analysts Set Expectations for COYA FY2025 Earnings
See More Headlines

COYA Stock Analysis - Frequently Asked Questions

Coya Therapeutics' stock was trading at $5.73 at the beginning of the year. Since then, COYA stock has increased by 15.9% and is now trading at $6.64.

Coya Therapeutics, Inc. (NASDAQ:COYA) released its earnings results on Tuesday, August, 12th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by $0.14. The business had revenue of $0.16 million for the quarter, compared to the consensus estimate of $0.78 million.

Coya Therapeutics (COYA) raised $15 million in an IPO on Thursday, December 29th 2022. The company issued 3,050,000 shares at $5.00 per share.

Coya Therapeutics' top institutional investors include AIGH Capital Management LLC (6.61%) and Northwestern Mutual Wealth Management Co. (0.12%). Insiders that own company stock include David S Snyder, Arun Swaminathan and Fred Grossman.
View institutional ownership trends
.

Shares of COYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Coya Therapeutics investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL), Adobe (ADBE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
8/12/2025
Today
8/28/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:COYA
CIK
1835022
Fax
N/A
Employees
6
Year Founded
N/A

Price Target and Rating

High Price Target
$18.00
Low Price Target
$14.00
Potential Upside/Downside
+148.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.88 million
Net Margins
N/A
Pretax Margin
-4,966.75%
Return on Equity
-61.05%
Return on Assets
-53.61%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.43
Quick Ratio
7.43

Sales & Book Value

Annual Sales
$3.55 million
Price / Sales
31.29
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.69 per share
Price / Book
3.93

Miscellaneous

Outstanding Shares
16,730,000
Free Float
14,718,000
Market Cap
$111.09 million
Optionable
Not Optionable
Beta
0.26

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:COYA) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners